fluoxetine has been researched along with Triple Negative Breast Neoplasms in 2 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira Rocha, AM | 1 |
| Severo Sabedra Sousa, F | 1 |
| Mascarenhas Borba, V | 1 |
| S Munchen, T | 1 |
| Guerin Leal, J | 1 |
| Dorneles Rodrigues, OE | 1 |
| G Fronza, M | 1 |
| Savegnago, L | 1 |
| Collares, T | 1 |
| Kömmling Seixas, F | 1 |
| Liao, PA | 1 |
| Chu, PY | 1 |
| Tan, ZL | 1 |
| Hsu, FT | 1 |
| Lee, YC | 1 |
| Wu, HJ | 1 |
1 review available for fluoxetine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Tran | 2022 |
1 other study available for fluoxetine and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Evaluation of the effect of synthetic compounds derived from azidothymidine on MDA-MB-231 type breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Female; Half-Life; Humans; S Phas | 2020 |